Table 1.
Comparison of cohort characteristics between those with and without late gadolinium enhancement
| No LGE | UMI | Non-specific LGE | P | |
|---|---|---|---|---|
| n (%) | 1463 (99.1) | 3 (0.2) | 7 (0.5) | |
| Male (%) | 561 (38) | 0 (0) | 1 (14) | 0.26 |
| Age (years) | 53.4 (40–80) | 62 (53–66) | 58.1 (50–67) | 0.13 |
| Pulse | 62 (35–92) | 67 (61–82) | 62 (54–70) | 0.44 |
| Systolic BP | 122 (80–145) | 118 (104–134) | 128 (102–140) | 0.71 |
| Diastolic BP | 72 (46–98) | 64 (58–76) | 68 (58–70) | 0.018 |
| Total cholesterol | 5.4 (2.7–9.5) | 5.4 (5.2–6.4) | 5.4 (4.6–7.2) | 0.87 |
| LDL-cholesterol (mmol/L) | 3.4 (0.9–6.8) | 3.3 (3.2–3.9) | 3.2 (2.3–4.7) | 0.96 |
| HDL-cholesterol (mmol/L) | 1.4 (0.4–2.6) | 1.8 (1.3–1.8) | 1.5 (0.9–2.3) | 0.94 |
| Triglycerides (mmol/L) | 1.3 (0.5–7) | 1.6 (0.5–1.7) | 1.1 (0.5–2.5) | 0.37 |
| Random glucose | 5.1 (3–11) | 5.3 (5–6) | 6.2 (5–8) | 0.11 |
| ASSIGN risk score | 7.4 (0.9–48) | 10.3 (10–13) | 6 (3–17) | 0.46 |
| BMI (kg/m2) | 26.1 (17–43) | 27.6 (25–29) | 22.9 (21–31) | 0.09 |
| Current/ex-smoker (%) | 552 (38) | 1 (33) | 3 (43) | 1 |
| Smoking pack years | 0 (0–105) | 0 (0–30) | 0 (0–57) | 0.91 |
| FH of CVD (%) | 377 (26) | 1 (33) | 0 (0) | 0.2 |
| BNP (pg/mL) | 22.7 (5–175) | 116 (31–133) | 22.6 (10–62) | 0.05 |
ASSIGN, ASsessing cardiovascular risk using SIGN guidelines; BMI, body mass index; BNP, brain natriuretic peptide; BP, blood pressure; CVD, cardiovascular disease; FH, family history; HDL, high density lipoprotein; LDL, low density lipoprotein; LGE, late gadolinium enhancement; UMI, unrecognized myocardial infarction.
Bold indicates statistical significance.